EP Patent

EP0326196B1 — Aqueous pharmaceutical preparation

Assigned to Akzo NV · Expires 1992-03-25 · 34y expired

What this patent protects

The present invention relates to a new pharmaceutical preparation for local application comprising an aqueous solution of 11 beta -hydroxy-16 alpha ,17 alpha ,21-trimethyl- &utrif& <1><,><4>-pregnadiene-3,20-dione and a beta -cyclodextrine derivative.

USPTO Abstract

The present invention relates to a new pharmaceutical preparation for local application comprising an aqueous solution of 11 beta -hydroxy-16 alpha ,17 alpha ,21-trimethyl- &utrif& <1><,><4>-pregnadiene-3,20-dione and a beta -cyclodextrine derivative.

Drugs covered by this patent

Patent Metadata

Patent number
EP0326196B1
Jurisdiction
EP
Classification
—
Expires
1992-03-25
Drug substance claim
No
Drug product claim
No
Assignee
Akzo NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.